Notice of Proposed Sale · 144
Dolby Laboratories, Inc.
DLBNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- DOLBY LABORATORIES, INC.
- Issuer CIK
- 0001308547
- SEC file number
- 001-32431
- Phone
- (415) 558-0200
- Person for whose account securities are to be sold
- JOHN COULING
- Relationships to issuer
- Officer
- Street
- 1275 Market Street
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94103-1410
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 7,667 | 450,689.26 | 59,416,894 | 10/01/2026 | NYSE | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 10/01/2026 | Stock Option Exercise | Issuer | 7,667 | N | 10/01/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| JOHN COULING | Common | 09/01/2026 | 7,667 | 468,032.02 |
| JOHN COULING | Common | 08/03/2026 | 7,667 | 460,003.90 |
Seller — prior-sale row 1, entry 1
- Name
- JOHN COULING
- Street
- 1275 Market Street
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94103-1410
Seller — prior-sale row 2, entry 1
- Name
- JOHN COULING
- Street
- 1275 Market Street
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94103-1410
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 10/01/2026
- Signed
- /s/ John David Couling
- Plan adoption dates
- 02/03/2026
Company context
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.